为青少年推出以关系为导向的行为服务阿片类药物使用障碍:药物决策和坚持规划方面的创新
Aaron Hogue1, Molly Bobek1, Nicole Porter1
1Family & Adolescent Clinical Technology & Science, Partnership to End Addiction, New York, USA.
Child & family behavior therapy
|September 28, 2023
概括
这项研究介绍了三种行为干预措施,以改善年轻成年人对阿片类药物使用障碍 (MOUD) 药物治疗的坚持和恢复. 这些灵活的,以人际关系为中心的方法消除障碍,并支持长期治疗的成功.
科学领域:
- 成 药物 药物 药物 药物
- 行为心理学 行为心理学
- 青少年健康 青少年健康
背景情况:
- 阿片类药物使用障碍 (OUD) 显著影响过渡年龄的年轻人 (16-25岁).
- 对阿片类药物使用障碍 (MOUD) 的药物治疗是有效的,但在年轻人群中面临挑战.
- 阻碍MOUD吸收和保留的障碍需要有针对性的干预措施.
研究的目的:
- 提出新的行为干预措施,以提高MOUD的吸收和保留在过渡年龄的青年.
- 描述三个相互关联,灵活的干预措施:关系导向,药物教育和决策支持,以及家庭领导和治疗坚持的所有权.
- 提供案例示例,展示针对不同青年个人资料的定制应用.
主要方法:
- 开发了三个以关系为导向的行为干预措施.
- 专注于解决阻碍MOUD吸收的障碍.
- 强调坚持规划和加强恢复.
主要成果:
- 干预措施旨在相互连接和灵活交付.
- 模块化方法允许根据客户的个性需求量身定制.
- 案例说明了实际应用和适应性.
结论:
- 行为干预可以显著改善青少年的MOUD参与和结果.
- 专注于关系的策略是克服坚持障碍的关键.
- 灵活的模块化干预为年轻成年人个性化OUD治疗提供了一个有希望的模型.
相关概念视频
Drug Therapy
60
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
60
Prescription, Nonprescription and Orphan Drugs
756
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
756
Drug Abuse and Addiction: Pharmacological Phenomena
501
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
501
Factors Affecting Drug Response: Overview
2.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
Drug Administration and Therapy Phases: Overview
504
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
504
Opioid Analgesics: Synthetic and Semisynthetic Opioids
326
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
326


